@article{TCR1119,
author = {Tetsuya Yamamoto and Koji Tsuboi and Kei Nakai and Hiroaki Kumada and Hideyuki Sakurai and Akira Matsumura},
title = {Boron neutron capture therapy for brain tumors},
journal = {Translational Cancer Research},
volume = {2},
number = {2},
year = {2013},
keywords = {},
abstract = {Boron neutron capture therapy (BNCT) is a unique method that can provide the delivery of tumor cell-selective high-linear energy transfer (LET) particle radiotherapy to tumor mass and the microscopic invasion while avoiding radiation damage to the surrounding normal brain tissue. The rationale of BNCT is based on the nuclear interaction of 10B with thermal neutrons with the release of high LET α and 7Li particles through the boron neutron capture reaction, 10B(n, α) 7Li. The very short path length (},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/1119}
}